GRANT ANDERSON: Open Payments
NPI 1578558946 · HEBRON, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$224 in 13 payments from 8 companies in 2025. Trend: 2023 $379 · 2024 $248 · 2025 $224
Food & beverage: $224
| Company | Payments | Amount |
|---|---|---|
| Viatris Specialty LLC | 3 | $56 |
| ABBVIE INC. | 3 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| PFIZER INC. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Phadia US Inc. | 1 | $15 |
Products named: YUPELRI, VRAYLAR, LEQVIO, CAPLYTA, EVENITY, NURTEC ODT, JARDIANCE, ImmunoCAP.
Industry payments across NE — which companies pay providers there.
